Company intelligence / Profile preview

Charles Associates

Wilmington, Massachusetts, United Statescharles-associates.com ↗

Ownership: Private
Employees: ~21000
Development stage: Other

Overview

Provides critical tools/services enabling drug discovery/development from target ID through preclinical/clinical testing; not directly reporting clinical results as it does not develop its own drugs

Therapeutic areas: Multiple
Modalities: Small moleculeMonoclonal antibodyCell therapyGene therapyBiologicVaccineRecombinant protein
Industry: Drug Discovery Services

Partnerships

National Cancer Institutemajor pharma/biotech clients globally

Beyond the preview

Go deeper on Charles Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Charles Associates.

Explore the full profile